Company Announcements

Publication of Final Terms

Source: RNS
RNS Number : 7721Q
easyJet PLC
02 March 2021
 

easyJet FinCo B.V.

2 March 2021

Publication of Final Terms

The Final Terms dated 1 March 2021 relating to the issue of EUR 1,200,000,000 1.875 per cent. Notes due 2028 by easyJet FinCo B.V., guaranteed by easyJet Airline Company Limited and easyJet plc are available for viewing.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/7721Q_1-2021-3-1.pdf

A copy of the Final Terms will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. This website is not provided for, or directed at, U.S. persons or persons in the United States.  If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

For further details please contact:

 

Institutional investors and analysts:

Michael Barker         Investor Relations                 +44 (0)7985 890 939

Holly Grainger          Investor Relations                 +44 (0)7583 101 913

Media:

Anna Knowles          Corporate Communications     +44 (0)7985 873 313

Edward Simpkins      Finsbury                               +44 (0)7947 740 551 / (0)207 251 3801

Dorothy Burwell       Finsbury                                +44 (0)7733 294 930 / (0)207 251 3801

 

easyJet FinCo B.V.

Westerdoksdijk 423

1013 BX Amsterdam

The Netherlands

 

LEI: 2138005GUMKABRAKJU30

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in this announcement and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Circular dated 10 February 2021 (available at http://www.rns-pdf.londonstockexchange.com/rns/6880O_1-2021-2-10.pdf)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms and the Offering Circular you must ascertain from the Final Terms and the Offering Circular whether or not you are part of the intended addressees of the information contained therein.

 

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy, securities to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The notes and the guarantees referred to in the Final Terms and the Offering Circular (the "securities") have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the US and are subject to US tax law requirements. Subject to certain exceptions, the securities may not be offered or sold directly or indirectly within the US or to, or for the account or benefit of, US persons or to persons within the US, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Final Terms or the Offering Circular in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the securities in the United States.

 

Your right to access this service is conditional upon complying with the above requirement. Your right to access this service is conditional upon complying with the above requirement.

 

Manufacturer target market (EU MiFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or in the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTKZGGFNMVGMZM